Abstract:Background Endothelial death/dysfunction is a critical process in the development of cardiovascular diseases. Finding a source of endothelial cells (ECs) for regenerative medicine is a challenging yet fundamental issue. Induced pluripotent stem cells (iPSCs) constitute an attractive source of cells for transplantation because of their high proliferation and differentiation potential. Methods and Results In this study, we investigated the mechanisms regulating iPSC differentiation into ECs, focusing on miRNAs and their targets. Firstly, we established a differentiation protocol using collagen and VEGF to drive the functional differentiation of iPSCs into ECs. After 7 days, the cells strongly expressed EC markers such as VE-cadherin, Flk-1, vWF and eNOS and formed tubes on Matrigel culture. A parallel study was conducted on embryonic stem cells (ESCs) and iPSCs to analyze the synergistic effect of VEGF and shear stress in improving EC differentiation. Next, we compared the miRNA signature of undifferentiated and differentiated cells with VEGF for 3 days. Amongst the 5 validated miRNAs we focused on miR-21, previously shown to be involved in angiogenesis. Overexpression of miR-21 (pre-21) in pre-differentiated iPSCs induced EC marker upregulation, while inhibition miR-21 (LNA-21) produced the opposite effect. Accordingly, in vitro and in vivo capillary formation was increased by pre-21 and reduced by LNA-21. Interestingly, miR-21 overexpression increased TGFβ2 mRNA and secreted protein level, which was consistent with the strong upregulation of TGFβ-2 during VEGF-induced iPSC differentiation. In addition treatment of iPSCs with TGFβ-2 induced EC marker expression and in vitro tube formation through induction of VEGF secretion. Inhibition of SMAD3, a downstream effector of TGFβ-2, strongly decreased VE-cadherin expression, indicating the importance of the TGFβ-2 pathway in the differentiation process. Furthermore, TGFβ-2 neutralizing antibody inhibited miR-21 induced EC marker upregulation, indicating that TGFβ-2 is a required downstream effecter for miR-21-mediated EC differentiation. In silico target screening revealed PTEN as one of the predicted targets of miR-21. Our results confirmed that pre-21 significantly inhibited PTEN expression whereas LNA-21 induced it. Luciferase assay confirmed that miR-21directly binds to the 3’ UTR of PTEN, which is inhibited by a site-specific mutation. Since PTEN is the upstream negative regulator of AKT signaling pathway, we then confirmed that pre-21 induced Akt phosphorylation, while LNA-21 decreased it. Functionally, it was found that inhibition of miR-21 in vivo Matrigel assay revealed the significant influence on angiogenesis in animal models. Conclusion These data demonstrate that miR-21 directly targets the PTEN/Akt pathway, in which TGFβ-2 pathway regulated by miR-21 is also involved. Thus, the molecular mechanisms elucidated in this work might provide the basic information for stem cell therapy for vascular disease, e.g. tissue engineering and endothelial repair in damaged vessels.

MiR-92a regulates endothelial progenitor cells (EPCs) by targeting GDF11 via activate SMAD2/3/FAK/Akt/eNOS pathway

High Glucose And Free Fatty Acids Induce Endothelial Progenitor Cell Senescence Via Pgc-1 Alpha/Sirt1 Signaling Pathway

MicroRNAs As Potential Novel Therapeutic Targets and Tools for Regulating Paracrine Function of Endothelial Progenitor Cells

MiR-21 Suppresses Endothelial Progenitor Cell Proliferation by Activating the TGFβ Signaling Pathway Via Downregulation of WWP1.

MicroRNA-210-3p Targets RGMA to Enhance the Angiogenic Functions of Endothelial Progenitor Cells under Hypoxic Conditions

Microrna 107 Partly Inhibits Endothelial Progenitor Cells Differentiation Via Hif-1 Beta

183 ENDOTHELIAL LINEAGE DIFFERENTIATION FROM IPS CELLS IS REGULATED BY MIRNA-21/AKT AND TGF-Β2 PATHWAYS

MicroRNA-221 Inhibits the Transition of Endothelial Progenitor Cells to Mesenchymal Cells Via the PTEN/FoxO3a Signaling Pathway

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

Effects of Hypoxia Inducible Factor-1Α Activator on the Biological Behavior of Endothelial Progenitor Cells

Endothelial progenitor cell (EPCs)-derived exosomal miR-30d-5p inhibits the inflammatory response of high glucose-impaired fibroblasts by affecting the M1/M2 polarization of macrophages

Overexpression of Mir‑17‑5p Protects Against High Glucose‑induced Endothelial Cell Injury by Targeting E2F1‑mediated Suppression of Autophagy and Promotion of Apoptosis

MicroRNA-34a Targets Forkhead Box J2 to Modulate Differentiation of Endothelial Progenitor Cells in Response to Shear Stress.

EPC-Derived Exosomal miR-1246 and miR-1290 Regulate Phenotypic Changes of Fibroblasts to Endothelial Cells to Exert Protective Effects on Myocardial Infarction by Targeting ELF5 and SP1

Over-expression of Hepatocyte Growth Factor in Smooth Muscle Cells Regulates Endothelial Progenitor Cells Differentiation, Migration and Proliferation

Differential MicroRNA Expression Pattern in Endothelial Progenitor Cells During Diabetic Retinopathy

Enrichment of miR-17-5p enhances the protective effects of EPC-EXs on vascular and skeletal muscle injury in a diabetic hind limb ischemia model

Hyperglycemia and Advanced Glycation End Products Regulate Mir-126 Expression in Endothelial Progenitor Cells

Loading MiR-210 in Endothelial Progenitor Cells Derived Exosomes Boosts Their Beneficial Effects on Hypoxia/Reoxygeneation-Injured Human Endothelial Cells via Protecting Mitochondrial Function

Endothelial Lineage Differentiation from Induced Pluripotent Stem Cells is Regulated by MicroRNA-21 and Transforming Growth Factor Β2 (Tgf-Β2) Pathways

Retinal pigment epithelial cells secrete miR-202-5p-containing exosomes to protect against proliferative diabetic retinopathy